$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

불임 환자와 반복자연유산 환자에서 황체형성호르몬에 대한 연구
A Study of Luteinizing Hormone in Patients with Infertility and Recurrent Spontaneous Abortion 원문보기

대한불임학회지 = Korean journal of fertility and sterility, v.29 no.2, 2002년, pp.91 - 96  

남윤성 (포천중문 의과대학 산부인과학교실) ,  조용선 (포천중문 의과대학 산부인과학교실) ,  이우식 (포천중문 의과대학 산부인과학교실) ,  김남근 (포천중문 의과대학 임상의학연구소) ,  김세현 (포천중문 의과대학 임상의학연구소) ,  차광렬 (포천중문 의과대학 산부인과학교실)

Abstract AI-Helper 아이콘AI-Helper

Objective : To evaluate luteinizing hormone (LH) in patients with infertility and recurrent spontaneous abortion. Material and Method: LH was tested by solid phase immunoradiometric assay based on monoclonal and polyclonal anti-LH antibodies. Results: Of 100 infertile patients, the number of less th...

주제어

참고문헌 (30)

  1. Homburg R, Eshel A, Armar NA. One hundred pregnancies after treatment with pulsatile luteinizing hormone releasing hormone to induce ovulation. Br Med J 1989; 298: 809-12 

  2. Homburg R, Armar NA, Eshel A, Adams J, Jacobs HS. Influence of serum luteinizing hormone concentrations on ovulation, conception, and early pregnancy loss in polycystic ovary syndrome. Br Med J 1988; 297: 1024-6 

  3. Homburg R, Jacobs HS. Etiology of miscarriage in polycystic ovary syndrome. Fertil Steril 1989; 51: 196-7 

  4. Regan L, Owen EJ, Jacobs HS. Hypersecretion of luteinizing hormone, infertility, and miscarriage. Lancet 1990; 336: 1141-4 

  5. Shoham Z, Borenstein R, Lunenfeld B, Pariente C. Hormonal profiles following clomiphene citrate therapy in conception and non-conception cycles. Clin Endocrinol 1990; 33: 271-8 

  6. Howles CM, Macamee MC, Edwards RG, Goswamy R, Steptoe Pc. Effect of high tonic luteinizing hormone on outcome of in-vitro fertilization. Lancet 1986; 2: 521-2 

  7. Punnonen R, Heinonen PK, Ashom R, Kujansuu E, Vilja P, Tuohimaa P. Spontaneous luteinizing hormone surge and cleavage of in-vitro fertilized embryos. Fertil Steril 1998; 49: 479-82 

  8. Stanger JD, Yovich JL. Reduced in-vitro fertilization of human oocytes from patients with raised basal LH levels during the follicular phase. Br J Obstet Gynaecol 1985; 92: 385-93 

  9. Gysler M, March CM, Mishell DR, Bailey EJ. A decade's experience with an individualized clomiphene treatment regimen including its effect on a postcoital test. Fertil Steril 1982; 37: 161-7 

  10. Tsafiri A, Pomerantz SH. Oocyte maturation inhibitor. Clin Endocrinol Metab 1986; 15: 157-70 

  11. Guerrero R, Rojas OI. Spontaneous abortion and aging of human ova and spermatozoa. N Engl J Med 1975; 293: 573-5 

  12. Hunter RHF, Cook B, Baker TG. Dissociation of response to injected gonadotropin between the graafian follicle and oocyte in pigs. Nature (London) 1976; 260: 156-8 

  13. Sagle M, Bishop K, Ridley N, Alexander FM, Michel M, Bonney RC, et al. Recurrent early miscarriage and polycystic ovaries. Br Med J 1988; 297: 1027-8 

  14. Filicori M, Flamigni C, Meriggiola MC, Ferrari L, Michelacci L, Campaniello E, et al. Endocrine response determines the clinical outcome of pulsatile gonadotropin-releasing hormone ovulation induction in different ovulatory disorders. J Clin Endocrinol Metab 1991; 72: 965-72 

  15. Hombrug R, Eshel A, Kilborn J, Adams J, Jacobs HS. Combined luteinizing hormone analogue and exogenous gonadotropins for the treatment of infertility associated with polycystic ovaries. Hum Reprod 1990; 5: 32-5 

  16. Johnson P, Pearce JM. Recurrent spontaneous abortion and polycystic ovarian disease: comparison of two regimens to induce ovulation. Br Med J 1990; 300: 154-6 

  17. Balen AH, Conway GS, Kaltas G. Polycystic ovary syndrome: the spectrum of the disorder in 1741 patients. Hum Reprod 1995; 10: 2107-11 

  18. Bonney RC, Frank S. The endocrinology of implantation and early pregnancy. Bailliere's Clin Endocrinol Metab 1990; 4: 207-31 

  19. Polson DW, Chanda M, Bedi S, Troup S, Lieberman B. The effect of serum luteinizing hormone concentrations on success rates of frozen embryo replacement into natural cycles. Br Congr Obstet Gynecol 1992 abstr 152 

  20. Hamilton-Fairley D, Kiddy D, Watson H, Paterson C, Franks S. Association of moderate obesity with a poor pregnancy outcome in women with polycystic ovary syndrome treated with low dose gonadotropin. Br J Obstet Gynecol 1992; 99: 128-31 

  21. Buckler HM, McLachlan RI, MacLachlan VB, Healy DL, Burger HG. Serum inhibin levels in poly-cystic ovary syndrome: basal levels and response to luteinising hormone-releasing hormone agonist and exogenous gonadotrophin administration. J Clin Endocrinol Metab 1988;66: 798-803 

  22. Sopelak VM, Hodgen GD. Blockade of the estrogen-induced luteinising hormone surge in monkeys: a nonsteroidal, antigenic factor in porcine follicular fluid. Fertil Steril 1984; 41: 108-13 

  23. Messinis IE, Templeton A, Baird DT. Endogenous luteinising hormone surge during superovulation induction with sequential use of clomiphene citrate and pulsatile human menopausal gonadotrophin. J Clin Endocrinol Metab 1985; 61: 1076-80 

  24. Balen AH, Jacobs HS. Gonadotrophin surge attenuating factor: a missing link in the control of LH secretion? Clin Endocrinol 1991; 35: 399-402 

  25. Homburg R, Eshel A, Kilborn J, Jacobs HS. Combined luteinising hormone releasing hormone analogue and exogenous gonadotrophins for the treatment of infertility associated with polycystic ovaries. Hum Reprod 1990; 5: 32-5 

  26. Jacobs HS. Polycystic ovaries and polycystic ovary syndrome. Gynecol Endocrinol 1987; 1: 113-31 

  27. Balen AH, Tan SL, MacDougall J, Jacobs HS. Miscarriage rates following in vitro fertilization are increased in women with polycystic ovaries and reduced by pituitary desensitization with buserelin. Hum Reprod 1993; 8: 959-64 

  28. Fleming R, Jamieson ME, Hamilton MP, Black WP, Macnaughton MC, Coutts JR. The use of GnRH analogues in combination with exogenous gonadotropins in infertile women. Acta Endocrinol (Suppl) 1988; 288:77-84 

  29. Abdalla HI, Ahuja KK, Leonard T, Morris NN, Honour JW, Jacobs HS. Comparative trial of luteinising hormone releasing hormone analogue / HMG and clomiphene citrate / HMG in an assisted conception programme. Fertil Steril 1990; 53:473-8 

  30. Tan SL, Waterstone J, Waren M, Parsons J. A prospective randomized study of the optimum timing of human chorionic gonadotropin administration after pituitary desensitization in vitro fertilisaiton. Fertil Steril 1992; 57: 1259-64 

섹션별 컨텐츠 바로가기

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

AI-Helper 아이콘
AI-Helper
안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

선택된 텍스트

맨위로